-
1 Comment
Kopran Limited is currently in a long term uptrend where the price is trading 65.4% above its 200 day moving average.
From a valuation standpoint, the stock is 77.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.1.
Kopran Limited's total revenue rose by 11.8% to $1B since the same quarter in the previous year.
Its net income has increased by 148.8% to $157M since the same quarter in the previous year.
Finally, its free cash flow grew by 104.9% to $347M since the same quarter in the previous year.
Based on the above factors, Kopran Limited gets an overall score of 5/5.
| Sector | Healthcare |
|---|---|
| Industry | Drug Manufacturers - General |
| Exchange | NSE |
| CurrencyCode | INR |
| ISIN | INE082A01010 |
| Target Price | 74 |
|---|---|
| Dividend Yield | 1.5% |
| Market Cap | 9B |
| Beta | 0.56 |
| PE Ratio | 24.15 |
Kopran Limited, an integrated pharmaceutical company, engages in the manufacture and marketing of active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, syrups, dry powder, suspension, and injectables, as well as branded and generic formulations. It also provides drugs in the categories of macrolide, antibacterial, anticonvulsant, anti-hypertensive, anti-helmentics, anti-acne, anti-infective, anti-thrombotic, antidiabetic, pain management, neuromodular, gastroenterology, and cardiovascular. In addition, the company provides drugs for erectile dysfunction, antiallergics, respiratory, oncology, central nervous system, antiprotozoal, anthelmintics, antipeptic ulcer and gut, and others. Kopran Limited was incorporated in 1958 and is based in Mumbai, India.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for KOPRAN.NSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
